Search the Newsreel

PCCP, Stonemont Close on $1B-Plus Acquisition of Blackstone Industrial Portfolio

PCCP and Stonemont Financial Group have successfully acquired a 5.9 million-square-foot industrial portfolio from Blackstone for over $1 billion. The portfolio comprises 38 assets across 14 markets in 10 states, with Eastdil Secured advising on the off-market transaction. The joint venture plans to focus …

MBX Biosciences (NASDAQ:MBX) Trading 8.5% Higher on Analyst Upgrade

MBX Biosciences (NASDAQ:MBX) saw its shares increase by 8.5% following an analyst upgrade from Mizuho, which raised its price target from $57 to $91 and maintained an "outperform" rating. The clinical-stage biopharmaceutical company holds a consensus "Moderate Buy" rating from analysts, with an average …

Blackstone (BX) Stock May Be Fully Priced As Q2 AI Profit Jumps

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Blackstone stock has delivered a 37.4% gain over the past three years, yet current checks suggest the shares trade at a premium, with both the Excess Returns …

Is the Private Credit Boom a Gift or a Risk for BDC Income Investors?

Business development companies (BDCs) are specifically designed to pass income on to investors. Some have particularly large yields, as well, often in the 10% area. However, there are important risks for investors to consider when buying a BDC. One of the biggest is the …

BXP Q2 FFO & Revenues Beat Estimates on Occupancy Gains, '26 View Up

BXP, Inc. BXP reported second-quarter 2026 funds from operations (FFO) of $1.78 per share, beating the Zacks Consensus Estimate of $1.71. FFO rose 4.1% from the year-ago period. Results reflected higher occupancy and same-property net operating income (NOI) growth,which supported the FFO beat. Total …

LemonEdge announces $21M Series A funding round led by Blackstone Innovations Investments and joined by BNY, to modernize private markets infrastructure – Company Announcement - FT.com

LemonEdge, a fund accounting platform for private markets, has secured a $21 million Series A funding round led by Blackstone Innovations Investments and joined by BNY, bringing its total funding to over $30 million. The company plans to use the investment to accelerate product …

Blackstone (BX) Leads Kuwait Pipeline Deal In Record Foreign Investment

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Blackstone (NYSE:BX) is leading a consortium in a joint venture with Kuwait Oil Company. The deal is structured as a 20.5-year lease and …

Blackstone Inc. Revenue Breakdown – NYSE:BX

This article provides a brief overview of Blackstone Inc.'s revenue breakdown. Last year, the company generated $13.08 billion USD, with Private Equity being its top-performing segment at $5.06 billion USD. The United States was the largest geographical contributor, accounting for $9.83 billion USD.

How Blackstone Put Jersey Mike’s on a Fast Track to This Week’s IPO

Blackstone acquired a majority stake in Jersey Mike's Subs early last year for approximately $6 billion plus debt and initiated various changes, including reining in corporate expenses. After 18 months, Jersey Mike's is poised to debut on the New York Stock Exchange under the …

UBS maintains Boston Properties stock rating on raised guidance By Investing.com

UBS reiterated a Neutral rating and $61.00 price target on Boston Properties Inc. (NYSE:BXP) after the company reported strong second-quarter 2026 results and raised its full-year outlook. The company increased its 2026 funds from operations guidance, improved occupancy rates, and successfully secured new financing …

MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Rating of "Moderate Buy" from Analysts

MBX Biosciences, Inc. (NASDAQ:MBX) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $66.75. This recommendation is based on nine buy ratings, one strong-buy, and two sell ratings. Several institutional investors have recently increased their holdings in …

MBX Biosciences Inc Today's Market Trends | MBX Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

MBX Biosciences Inc (MBX) is currently trading at $60.02, down 2.09% today, but showing significant gains over the past year. The company, a clinical-stage biopharmaceutical firm focusing on endocrine and metabolic disorders, has a "Buy" rating from analysts with an average target price of …

New Mexico residents turn out to UNM campus to weigh in on proposed private equity takeover of PNM

New Mexico residents gathered at the University of New Mexico to discuss Blackstone Infrastructure's proposed $11.5 billion merger with TXNM Energy Inc., the parent company of PNM. The acquisition has been controversial, especially after the Public Regulation Commission ruled that Blackstone and PNM violated …

Boston Properties (BXP) Q2 FFO and Revenues Surpass Estimates

Boston Properties (BXP) reported Q2 FFO of $1.78 per share, exceeding the Zacks Consensus Estimate of $1.71, and revenues of $831.68 million, surpassing estimates by 2.36%. The company has exceeded FFO estimates three times and revenue estimates three times over the last four quarters. …

Boston Properties (BXP) Reports Q2 Earnings: What Key Metrics Have to Say

Boston Properties (BXP) reported its Q2 2026 earnings, showcasing a revenue of $831.68 million and EPS of $1.78, surpassing Zacks Consensus Estimates. The article highlights key metrics such as occupancy rates, revenue from various segments, and net earnings per share, comparing them to analyst …

BXP Secures $1.2 Billion Construction Loan for 343 Madison Avenue

Financing Completed for Premier Midtown Manhattan Development BOSTON, July 28, 2026--(BUSINESS WIRE)--BXP, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that it has closed a $1.2 billion construction loan for the development …

BXP Announces Second Quarter 2026 Results

Executed Approximately 1.8 Million SF of Leases in Q2; Increased Total Portfolio Occupancy by 100 Basis Points BOSTON, July 28, 2026--(BUSINESS WIRE)--BXP, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, reported results today for …

Boston Properties: Q2 Earnings Snapshot

Boston Properties Inc. (BXP) reported its Q2 earnings, surpassing Wall Street expectations for profitability. The real estate investment trust posted funds from operations of $1.78 per share, exceeding analyst estimates of $1.71 per share, and revenue of $895.7 million, with adjusted revenue of $831.7 …

EcoR1 Capital LLC Decreases Stock Position in MBX Biosciences, Inc. $MBX

EcoR1 Capital LLC significantly reduced its stake in MBX Biosciences (NASDAQ:MBX) by 63.4% during Q1, selling 1.35 million shares but still holding 777,000 shares valued at $23.2 million. Despite this, analysts maintain a "Moderate Buy" rating with an average price target of $66.75, with …

U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics

This article provides a comprehensive roundup of U.S. Wall Street securities analysts' revised ratings and price targets for numerous U.S.-listed companies, including major players like Blackstone, Hartford Insurance, and Zevra Therapeutics. The report details upgrades, downgrades, and new coverage initiations from various firms, offering …

Blackstone's $11.5 billion acquisition of PNM faces regulatory scrutiny and ratepayer concerns

Blackstone's $11.5 billion acquisition of PNM (parent company TXNM Energy) is under regulatory scrutiny due to an unapproved $400 million stock transaction. A climate action group warns that the acquisition could lead to higher power bills for New Mexico residents, drawing parallels to an …

BXP Q2 2026 Earnings Preview

* BXP (BXP [https://seekingalpha.com/symbol/BXP]) is scheduled to announce Q2 earnings results on Tuesday, July 28th, after market close. * The consensus EPS Estimate is $0.43 [https://seekingalpha.com/symbol/BXP/earnings/estimates] and the consensus Revenue Estimate is $871.43M * Over the last 3 months, EPS estimates have seen 1 …

MBX Biosciences Inc (MBX) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial analysis of MBX Biosciences Inc (MBX), focusing on its profitability and balance sheet. As of the close on July 27, the company's stock was trading at $61.267, experiencing a slight decline of 1.18%. Key financial indicators like market capitalization …

MarineMax sale talks reportedly enter final round with three competing bidders

MarineMax is reportedly in the final stages of sale talks, with three prominent firms—Blackstone, Donerail, and Centerbridge—competing for a deal. Some shareholders believe a carve-out of MarineMax's lucrative marina and yacht-servicing operations, Island Global Yachting (IGY), acquired in 2022, would attract the most buyer …

Blackstone CEO Says AI Megatrend Is Creating 'Extraordinary' Growth Opportunities

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Blackstone Inc. reported second-quarter results on Thursday that topped Wall Street expectations, as strong fee-related earnings, fundraising and AI-driven investments boosted profitability. Blackstone Earnings Top Estimates Distributable …

After a Beat, Blackstone (BX) Still Has to Convince the Market

Blackstone Inc. (NYSE:BX), among the largest alternative asset managers with more than $1.3 trillion under management, delivered a broad earnings beat and addressed investor concerns over realizations and retail redemptions, yet shares struggled to hold gains as investors continued to question when earnings normalization …

Blackstone to open office in Kuwait as it expands in GCC region (BX:NYSE)

Blackstone, the world's largest alternative asset manager, announced its plan to open an office in Kuwait through the Kuwait Direct Investment Promotion Authority. This move is part of the company's strategy to strengthen its presence in the Gulf Cooperation Council (GCC) region. The announcement …

MBX Biosciences, Inc. $MBX is Orbimed Advisors LLC's 10th Largest Position

Orbimed Advisors LLC recently reduced its stake in MBX Biosciences by 7.6%, but it still holds 3.64 million shares, making it their 10th largest position. Despite Orbimed’s reduction, other institutional investors, such as Russell Investments and Royal Bank of Canada, increased their holdings. MBX …

Public Employees Retirement System of Ohio Sells 24,934 Shares of BXP, Inc. $BXP

SoftBank nears $625M acquisition of payments firm SP.LINKS from Blackstone - report

SoftBank is reportedly close to acquiring the Japanese payments firm SP.LINKS from Blackstone for approximately $625 million (¥100 billion). SoftBank has emerged as the preferred bidder in an auction for the company.

MBX Biosciences Inc (MBX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of MBX Biosciences Inc. (MBX) stock, focusing on its dividend and stock split history. It notes that the company has distributed no dividends over the past five years. Key financial data like market capitalization and recent stock performance are …

Blackstone Unit to Buy HSBC’s Australian Loan Book, AFR Says

Blackstone Inc.'s private credit division is reportedly set to acquire HSBC Holdings Plc's Australian loan book, valued at over A$30 billion ($21 billion). This acquisition would signify Blackstone's entry into the Australian home lending market. Other firms like KKR & Co. and Apollo Global …

Retail Investors Are Pulling Money From Blackstone's Private Credit Fund. Here's What Its Latest Quarter Says.

Key Points Investors continue to withdraw capital from Blackstone's flagship private credit fund. That didn't affect its financial results. The company's AI investments are driving its growth. 10 stocks we like better than Blackstone › Concerns about the private credit market have prompted investors …

MBX Biosciences, Inc. Revenue Breakdown – NASDAQ:MBX

This article provides details for accessing financial information, including revenue breakdown, for MBX Biosciences, Inc. (NASDAQ:MBX) on TradingView. It highlights the availability of fundamentals, stats, and various financial statements for the biotechnology company. The content primarily serves as a directory for users interested in …

Blackstone Secured Lending Fund (NYSE:BXSL) Given Consensus Rating of "Hold" by Analysts

Blackstone Secured Lending Fund (BXSL) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $24.78. Recent downgrades from several firms reflect increasing caution, despite the company beating Q1 earnings estimates with $0.77 per share and declaring a quarterly …

MBX|MBX Biosciences Inc|Price:62.000|Chg%:-1.570

MBX Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing precision peptide therapies for endocrine and metabolic disorders. The article provides an overview of the company's product candidates, including MBX 2109, MBX 1416, and its Obesity portfolio, designed for conditions like hypoparathyroidism and …